NCT00232206View on ClinicalTrials.gov

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

November 30, 2007

Conditions
Non-small-Cell Lung Carcinoma
Interventions
DRUG

Neoadjuvant Therapy with Cisplatin Plus Docetaxel

Trial Locations (1)

97213

Providence Portland Medical Center, Portland

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Providence Cancer Center, Earle A. Chiles Research Institute

OTHER

collaborator

Sanofi

INDUSTRY

lead

Providence Health & Services

OTHER